Identification of Sialyltransferase 8B as a Generalized Susceptibility Gene for Psychotic and Mood Disorders on Chromosome 15q25-26

University of Illinois at Chicago, United States of America
PLoS ONE (Impact Factor: 3.23). 05/2012; 7(5):e38172. DOI: 10.1371/journal.pone.0038172
Source: PubMed


We previously identified a significant bipolar spectrum disorder linkage peak on 15q25-26 using 35 extended families with a broad clinical phenotype, including bipolar disorder (types I and II), recurrent unipolar depression and schizoaffective disorder. However, the specific gene(s) contributing to this signal had not been identified. By a fine mapping association study in an Australian case-control cohort (n = 385), we find that the sialyltransferase 8B (ST8SIA2) gene, coding for an enzyme that glycosylates proteins involved in neuronal plasticity which has previously shown association to both schizophrenia and autism, is associated with increased risk to bipolar spectrum disorder. Nominal single point association was observed with SNPs in ST8SIA2 (rs4586379, P = 0.0043; rs2168351, P = 0.0045), and a specific risk haplotype was identified (frequency: bipolar vs controls = 0.41 vs 0.31; χ(2) = 6.46, P = 0.011, OR = 1.47). Over-representation of the specific risk haplotype was also observed in an Australian schizophrenia case-control cohort (n = 256) (χ(2) = 8.41, P = 0.004, OR = 1.82). Using GWAS data from the NIMH bipolar disorder (n = 2055) and NIMH schizophrenia (n = 2550) cohorts, the equivalent haplotype was significantly over-represented in bipolar disorder (χ(2) = 5.91, P = 0.015, OR = 1.29), with the same direction of effect in schizophrenia, albeit non-significant (χ(2) = 2.3, P = 0.129, OR = 1.09). We demonstrate marked down-regulation of ST8SIA2 gene expression across human brain development and show a significant haplotype×diagnosis effect on ST8SIA2 mRNA levels in adult cortex (ANOVA: F(1,87) = 6.031, P = 0.016). These findings suggest that variation the ST8SIA2 gene is associated with increased risk to mental illness, acting to restrict neuronal plasticity and disrupt early neuronal network formation, rendering the developing and adult brain more vulnerable to secondary genetic or environmental insults.

Download full-text


Available from: Philip Bowden Mitchell,
  • Source
    • "This rare haplotype is present in the patient's mother, along with the most common haplotype (freq ¼ 0.723). Neither of these maternal haplotypes are represented by the risk or protective haplotypes previously reported to be associated with bipolar disorder and schizophrenia [McAuley et al., 2012]. The rarity of the remaining haplotype in the patient suggests the deletion event may have arisen on the paternal chromosome, either through direct inheritance or a de novo mutational event, although DNA from the father would be required to confirm this. "

    American Journal of Medical Genetics Part A 04/2015; 167(6). DOI:10.1002/ajmg.a.36846 · 2.16 Impact Factor
  • Source
    • "Recently, a relationship between SNPs in the promoter region of the ST8SIA2 gene and schizophrenia was identified by genome-wide association studies in the Japanese (Arai et al., 2006) and Chinese Han populations (Tao et al., 2007). The ST8SIA2 gene is also reported to be a generalized susceptibility marker for psychotic and mood disorders on chromosome 15q25-26 (McAuley et al., 2012), and is associated with an increased risk of mental illness, such as autism (Anney et al., 2010). Interestingly, the mutation of synCAM, which is another substrate for ST8SIA2, is also related with autism spectrum disorders (Zhiling et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Psychiatric disorders are a group of human diseases that impair higher cognitive functions. Whole-genomic analyses have recently identified susceptibility genes for several psychiatric disorders, including schizophrenia. Among the genes reported to be involved in psychiatric disorders, a gene encoding a polysialyltransferase involved in the biosynthesis of polysialic acid (polySia or PSA) on cell surfaces has attracted attention for its potential role in emotion, learning, memory, circadian rhythm, and behaviors. PolySia is a unique polymer that spatio-temporally modifies neural cell adhesion molecule (NCAM) and is predominantly found in embryonic brains, although it persists in areas of the adult brain where neural plasticity, remodeling of neural connections, or neural generation is ongoing, such as the hippocampus, subventricular zone (SVZ), thalamus, prefrontal cortex, and amygdala. PolySia is thought to be involved in the regulation of cell-cell interactions; however, recent evidence suggests that it is also involved in the functional regulation of ion channels and neurologically active molecules, such as Brain-derived neurotrophic factor (BDNF), FGF2, and dopamine (DA) that are deeply involved in psychiatric disorders. In this review, the possible involvement of polysialyltransferase (ST8SIA2/ST8SiaII/STX/Siat8B) and its enzymatic product, polySia, in schizophrenia is discussed.
    Frontiers in Cellular Neuroscience 05/2013; 7:61. DOI:10.3389/fncel.2013.00061 · 4.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The glycan polysialic acid is well-known as a unique posttranslational modification of the neural cell adhesion molecule NCAM. Despite remarkable acceptor specificity, however, a few other proteins can be targets of polysialylation. Here, we recapitulate the biosynthesis of polysialic acid by the two polysialyltransferases ST8SIA2 and ST8SIA4 and highlight the increasing evidence that variation in the human ST8SIA2 gene is linked to schizophrenia and possibly other neuropsychiatric disorders. Moreover, we summarize the knowledge on the role of NCAM polysialylation in brain development gained by the analysis of NCAM- and polysialyltransferase-deficient mouse models. The last part of this review is focused on recent advances in identifying SynCAM 1 and neuropilin-2 as novel acceptors of polysialic acid in NG2 cells of the perinatal brain and in dendritic cells of the immune system, respectively.
    Neurochemical Research 01/2013; 38(6). DOI:10.1007/s11064-013-0979-2 · 2.59 Impact Factor
Show more